Thus, in our study, we aimed to increase the percentage of CD8+ T cells in the tumor tissue by locally injecting anti‐PD‐L1‐DOX‐R848‐MIP‐3α/TKNP in 4T1 tumor‐bearing mice. The gene discussed is CCL20; the disease is neoplasm.